Public Policy
The company's Precision DL speeds up screening time, enhances the image quality of PET/CT scans and improves small lesion detection.
The company's iPredict System allows providers to detect age-related macular degeneration in the clinical setting.
HIMSS23
Digital therapeutics improve access to care, but face reimbursement challenges. Jessica Hauflaire, COO of the Digital Therapeutics Alliance, describes the DTA's work with CMS and policymakers to gain support for this new care model.
HIMSS23
Lawrence Voyten, HIMSS board member and national advocacy chair, details how HIMSS chapter leaders can proactively support health equity and interoperability with their local governments.
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the market for digital therapeutics after Pear Therapeutics declared bankruptcy.
The company's ANNE One platform allows for wireless monitoring of neonates and infants' skin and body temperature, heart and respiratory rates, and more.
The feature monitors heart rhythms suggestive of atrial fibrillation through the Galaxy Watch.
According to an audit by the Office of the Inspector General, Medicare improperly paid for $580 million of psychotherapy care, including $348 million of telehealth services, during the first year of the COVID-19 public health emergency.
The startup plans to file with the FDA to add other monitoring abilities and to introduce the product later this year.
HIMSS23
Drew Ivan, Rhapsody's chief strategy officer, discusses how health systems can leverage digital solutions to manage data more efficiently while building regulatory compliance and flexibility into their IT infrastructure.